E70.338 Other albinism with hematologic abnormality

Name of the Condition

• Other albinism with hematologic abnormality (ICD-10-CM Code: E70.338)

Summary

Other albinism with hematologic abnormality is a genetic condition characterized by reduced or absent melanin production, affecting pigmentation of the skin, hair, and eyes, alongside associated hematologic abnormalities. This condition may lead to vision problems due to abnormal development of the optic nerves and retinas, and hematologic findings may include anemia, leukopenia, or thrombocytopenia.

Causes

Other albinism with hematologic abnormality results from genetic mutations that disrupt melanin synthesis or transport, often involving genes critical for both pigmentation and hematopoiesis. These mutations impair melanin production, a pigment essential for normal pigmentation and eye development, and may also affect blood cell formation.

Risk Factors

• Genetic inheritance; typically autosomal recessive, requiring mutations in both copies of a gene.
• Family history of albinism with hematologic abnormalities.
• Higher carrier rates in certain populations for specific genetic variants.

Symptoms

• Pale skin, light hair, and light-colored eyes.
• Vision issues, including nystagmus, strabismus, photophobia, and reduced visual acuity.
• Hematologic abnormalities, such as anemia, leukopenia, or thrombocytopenia.
• Increased susceptibility to sunburn and skin damage.

Diagnosis

Diagnosis involves a physical exam to assess pigmentation and hematologic signs, blood tests to evaluate blood cell counts and function, and genetic testing to identify specific mutations. Ophthalmologic evaluation may also be performed to assess vision-related abnormalities.

Treatment Options

Treatment focuses on managing symptoms and complications. This may include vision correction (e.g., glasses, contact lenses), sun protection (e.g., sunscreen, protective clothing), and hematologic support (e.g., blood transfusions, medications for anemia or immune function). Genetic counseling is often recommended.

Prognosis and Follow-Up

Prognosis varies depending on the severity of hematologic and vision-related complications. Regular follow-up with healthcare providers, including ophthalmologists and hematologists, is important to monitor and manage symptoms. Early intervention can help improve quality of life.

Complications

• Severe vision impairment or blindness.
• Increased risk of skin cancer due to sun sensitivity.
• Recurrent infections or bleeding disorders from hematologic abnormalities.
• Developmental delays in some cases.

Lifestyle & Prevention

• Use sunscreen and protective clothing to reduce sunburn risk.
• Regular eye exams to monitor vision changes.
• Avoid activities that increase injury risk due to bleeding tendencies.
• Genetic counseling for family planning and risk assessment.

When to Seek Professional Help

Seek medical attention if experiencing sudden vision changes, unexplained bruising or bleeding, persistent fatigue (possible anemia), or signs of infection. Prompt evaluation is important for managing complications.

Tips for Medical Coders

Document the presence of albinism and specific hematologic abnormalities (e.g., anemia, leukopenia) to support code assignment. Ensure clinical documentation aligns with the ICD-10-CM code E70.338, specifying the type of hematologic abnormality when available.